Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 4Pancreatic Adenocarcinoma 1Colonic Neoplasms 1Cholangiocarcinoma 1

Interventions

Gemcitabine 7Albumin-Bound Paclitaxel 5Taxes 4Fluorouracil 4dehydroftorafur 3Radiotherapy 3Oxaliplatin 3Radiotherapy, Intensity-Modulated 2Losartan 2Leucovorin 2Irinotecan 2130-nm albumin-bound paclitaxel 2irinotecan sucrosofate 1indusatumab 1X-Rays 1Surgical Procedures, Operative 1Specimen Handling 1S 1 (combination) 1Radiotherapy, Image-Guided 1Radiation 1Pancreatectomy 1Folfox protocol 1Erlotinib Hydrochloride 1Cetuximab 1Capecitabine 1Anesthesia, General 1Anesthesia 13-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Pancreatic Adenocarcinoma × Pancreatectomy × Clear all
NCT02562716 2022-10-19

S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery

SWOG Cancer Research Network

Phase 2 Completed
147 enrolled 16 charts
Gastrointestinal

Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡